Dr. Thaddeus Allen is a researcher turned biotech founder. He started Tradewind BioScience with the goal of translating research discoveries into novel therapeutics for patients with cancer. He continues to forge this path through innovation and team science. With more than 20 years of cancer research experience, Dr. Allen is an accomplished cancer biologist who trained in the laboratory of Nobel Laureate, J. Michael Bishop at the University of California, San Francisco. He earned his PhD from the University of Toronto in 2004. Prior to this he studied Biology/Pharmacology at McMaster University in Hamilton, Ontario, Canada.
Dr. Ron Buckanovich is a physician-scientist. He completed his medical training at Cornell University and received a PhD from the Rockefeller University in New York. He currently is a Professor of Medicine and of Obstetrics, Gynecology, and Reproductive Science at University of Pittsburgh Medical Center (UPMC). As co-leader of the Hillman Breast and Ovarian Cancer Program and Co-Director of the UPMC Ovarian Cancer Center of Excellence he actively leads clinical and translational research efforts. His research goals are to develop novel therapeutics and diagnostics for women with gynecological cancer and he is a pioneer in the field of ovarian cancer stem cells. He has received multiple honors in recognition of past work. Examples include a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation and the National Institutes of Health, New Innovator Directors Award. Dr. Buckanovich has been inducted into the prestigious American Society of Clinical Investigation (ASCI).